Most tumor cells show aberrantly activated Akt which leads to increased cell survival and resistance to cancer radiotherapy. Therefore, targeting Akt can be a promising strategy for radiosensitization. | Differential effects of the Akt inhibitor MK2206 on migration and radiation sensitivity of glioblastoma cells